Brokers Issue Forecasts for RAPT FY2026 Earnings
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) – Equities research analysts at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for shares of RAPT Therapeutics in a research report issued on Monday, March 10th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings of ($0.91) per share for the year. […]
